Martin Anetseder Selected Research

Succinylcholine (Suxamethonium Chloride)

3/2014	The effect of succinylcholine on malignant hyperthermia events in susceptible swine.
1/2013	A minimal-invasive metabolic test detects malignant hyperthermia susceptibility in a patient after sevoflurane-induced metabolic crisis.
8/2011	Succinylcholine in malignant hyperthermia: evaluation of a novel in vivo model.
5/2011	Magnesium does not influence the clinical course of succinylcholine-induced malignant hyperthermia.
9/2003	Caffeine impairs intramuscular energy balance in patients susceptible to malignant hyperthermia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Anetseder Research Topics

Disease

17	Malignant Hyperthermia 11/2015 - 05/2002
6	Contracture 01/2013 - 08/2003
1	Clostridium Infections 01/2016
1	Critical Illness (Critically Ill) 01/2016
1	Myotoxicity 08/2011
1	Disease Progression 05/2011
1	Muscular Diseases (Myopathy) 09/2003

Drug/Important Bio-Agent (IBA)

9	Caffeine (No Doz)FDA LinkGeneric 10/2015 - 05/2002
7	Halothane (Fluothane)FDA Link 01/2013 - 08/2003
5	Succinylcholine (Suxamethonium Chloride)FDA LinkGeneric 03/2014 - 09/2003
4	Lactic Acid (Lactate)FDA LinkGeneric 01/2010 - 08/2003
4	Carbon DioxideIBA 10/2007 - 05/2002
3	Sevoflurane (Ultane)FDA LinkGeneric 01/2013 - 10/2007
3	Anesthetics (Anesthetic Agents)IBA 08/2011 - 09/2003
2	FluoroquinolonesIBA 11/2015 - 08/2011
2	Dantrolene (Dantrium)FDA LinkGeneric 01/2013 - 10/2007
2	CalciumIBA 08/2011 - 09/2003
1	Inhalation AnestheticsIBA 01/2013
1	Levofloxacin (Levaquin)FDA Link 08/2011
1	Ciprofloxacin (Cipro)FDA LinkGeneric 08/2011
1	MagnesiumIBA 05/2011
1	Desflurane (I 653)FDA Link 04/2011
1	Isoflurane FDA LinkGeneric 04/2011
1	Enflurane (Ethrane)FDA LinkGeneric 04/2011
1	Neuromuscular Blocking AgentsIBA 03/2010
1	cyclopiazonic acidIBA 06/2005
1	Adenosine Triphosphatases (ATPase)IBA 06/2005
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 08/2003
1	RyanodineIBA 08/2003
1	AlkaloidsIBA 08/2003

Therapy/Procedure

5	Intramuscular Injections 01/2013 - 05/2002
1	Therapeutics 01/2016
1	General Anesthesia 01/2013